Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3525396016 | Product containing papaveretum and scopolamine hydrobromide (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3525397013 | Product containing papaveretum and scopolamine hydrobromide | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3666453017 | Hyoscine hydrobromide and papaveretum product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3666454011 | Papaveretum and scopolamine hydrobromide product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing papaveretum and scopolamine hydrobromide | Is a | Product containing papaveretum (medicinal product) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide | Has active ingredient | Opium preparation | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide | Has active ingredient | Papaveretum (substance) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide | Has active ingredient | Central nervous system agent (substance) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide | Has active ingredient | Opium | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide | Is a | Hyoscine hydrobromide | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide | Has active ingredient | Scopolamine hydrobromide (substance) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide | Is a | Scopolamine hydrobromide | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide | Is a | Product containing scopolamine in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide | Has manufactured dose form | Parenteral dose form (dose form) | false | Inferred relationship | Some | ||
| Product containing papaveretum and scopolamine hydrobromide | Is a | Product containing scopolamine (medicinal product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule | Is a | False | Product containing papaveretum and scopolamine hydrobromide | Inferred relationship | Some | |
| Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection ampule | Is a | False | Product containing papaveretum and scopolamine hydrobromide | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
Description inactivation indicator reference set
FHIR